Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Pakalapati, Ravi K
Bolisetty, Srinivas
Austin, Marie‐Paule
and
Oei, Julee
2006.
Neonatal seizures from in utero venlafaxine exposure.
Journal of Paediatrics and Child Health,
Vol. 42,
Issue. 11,
p.
737.
McAllister-Williams, R Hamish
2006.
Duloxetine in the management of depression.
Future Neurology,
Vol. 1,
Issue. 6,
p.
713.
Ramadan, Nabih M.
and
Buchanan, Thomas M.
2006.
New and future migraine therapy.
Pharmacology & Therapeutics,
Vol. 112,
Issue. 1,
p.
199.
Baghai, Thomas C.
Volz, Hans-Peter
and
Möller, Hans-Jürgen
2006.
Drug treatment of depression in the 2000s: an overview of achievements in the last 10 years and future possibilities.
The World Journal of Biological Psychiatry,
Vol. 7,
Issue. 4,
p.
198.
Deecher, Darlene C.
Beyer, Chad E.
Johnston, Grace
Bray, Jenifer
Shah, S.
Abou-Gharbia, M.
and
Andree, Terrance H.
2006.
Desvenlafaxine Succinate: A New Serotonin and Norepinephrine Reuptake Inhibitor.
The Journal of Pharmacology and Experimental Therapeutics,
Vol. 318,
Issue. 2,
p.
657.
HAINER, VOJTECH
KABRNOVA, KAROLINA
ALDHOON, BASHAR
KUNESOVA, MARIE
and
WAGENKNECHT, MARTIN
2006.
Serotonin and Norepinephrine Reuptake Inhibition and Eating Behavior.
Annals of the New York Academy of Sciences,
Vol. 1083,
Issue. 1,
p.
252.
Thase, Michael E.
Clayton, Anita H.
Haight, Barbara R.
Thompson, April H.
Modell, Jack G.
and
Johnston, J. Andrew
2006.
A Double-blind Comparison Between Bupropion XL and Venlafaxine XR.
Journal of Clinical Psychopharmacology,
Vol. 26,
Issue. 5,
p.
482.
Schwartz, Thomas L
and
Nihalani, Nikhil
2006.
Tiagabine in anxiety disorders.
Expert Opinion on Pharmacotherapy,
Vol. 7,
Issue. 14,
p.
1977.
Kim, H. Florence
and
Fisch, Michael J.
2006.
Antidepressant use in ambulatory cancer patients.
Current Oncology Reports,
Vol. 8,
Issue. 4,
p.
275.
King, Tamara
Rao, Srinivas
Vanderah, Todd
Chen, Qingmin
Vardanyan, Anna
and
Porreca, Frank
2006.
Differential Blockade of Nerve Injury–Induced Shift in Weight Bearing and Thermal and Tactile Hypersensitivity by Milnacipran.
The Journal of Pain,
Vol. 7,
Issue. 7,
p.
513.
Montgomery, Stuart
2006.
Serotonin noradrenaline reuptake inhibitors: Logical evolution of antidepressant development.
International Journal of Psychiatry in Clinical Practice,
Vol. 10,
Issue. sup2,
p.
5.
Zhang, Lu
Chappell, Jill
Gonzales, Celedon R
Small, David
Knadler, Mary P
Callaghan, JT
Francis, Jennie L
Desaiah, Durisala
Leibowitz, Mark
Ereshefsky, Larry
Hoelscher, David
Leese, Philip T
and
Derby, Michael
2007.
QT Effects of Duloxetine at Supratherapeutic Doses: A Placebo and Positive Controlled Study.
Journal of Cardiovascular Pharmacology,
Vol. 49,
Issue. 3,
p.
146.
Millan, Mark J.
and
Dekeyne, Anne
2007.
Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats: a characterization with α/β-adrenoceptor subtype selective ligands, antidepressants, and antagonists at neuropeptide receptors.
The International Journal of Neuropsychopharmacology,
Vol. 10,
Issue. 05,
Walter, Uwe
Prudente-Morrissey, Lara
Herpertz, Sabine C.
Benecke, Reiner
and
Hoeppner, Jacqueline
2007.
Relationship of brainstem raphe echogenicity and clinical findings in depressive states.
Psychiatry Research: Neuroimaging,
Vol. 155,
Issue. 1,
p.
67.
Lennestål, Roland
and
Källén, Bengt
2007.
Delivery Outcome in Relation to Maternal Use of Some Recently Introduced Antidepressants.
Journal of Clinical Psychopharmacology,
Vol. 27,
Issue. 6,
p.
607.
Kako, Yuki
Niwa, Yusuke
Toyomaki, Atsuhito
Yamanaka, Hiroyoshi
Kitagawa, Nobuki
Denda, Kenzo
and
Koyama, Tsukasa
2007.
A case of adult attention-deficit/hyperactivity disorder alleviated by milnacipran.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 31,
Issue. 3,
p.
772.
Nash, Jon
and
Nutt, David
2007.
Psychopharmacology of anxiety.
Psychiatry,
Vol. 6,
Issue. 4,
p.
143.
Kamath, Jayesh
DeMartinis, Nicholas
and
Handratta, Venkatesh
2007.
Efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder.
Future Neurology,
Vol. 2,
Issue. 4,
p.
361.
Wernicke, Joachim
Lled??, Alberto
Raskin, Joel
Kajdasz, Daniel K
and
Wang, Fujun
2007.
An Evaluation of the Cardiovascular Safety Profile of Duloxetine.
Drug Safety,
Vol. 30,
Issue. 5,
p.
437.
Millet, B.
2007.
Apport des ISRS et IRSNA dans l’anxiodépression.
L'Encéphale,
Vol. 33,
Issue. 4,
p.
699.